The Jersey City, NJ-based data analytics company provides information about risk to professionals in insurance, healthcare, financial services, government, supply chain and risk management industries.
The lower price target follows the release of the company's 2015 fourth quarter results earlier this week.
Verisk posted adjusted earnings of 80 cents per diluted share, topping analysts' expectations for earnings of 74 cents per share. Revenue climbed by 20.6% to $560.6 million year-over-year, but missed Wall Street's estimates of $566.43 million.
"Management provided some color on its 2016 expectations, which was mostly positive, in our view; insurance is expected to show 'at least' growth similar to 2015 (suggesting improvement), healthcare to accelerate, and financial services growth to be in the double-digits (though we believe likely slowing)," the firm said in an analyst note.
The company did not provide earnings guidance, BMO Capital noted.
Shares of Verisk closed higher by 3.14% to $73.90 on Thursday.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B on the stock.
This is driven by multiple strengths, which should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks covered.
The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, compelling growth in net income, expanding profit margins and solid stock price performance.
The team believes its strengths outweigh the fact that the company has had generally high debt management risk by most measures that were evaluated.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: VRSK